1[1]Plouet J,Moro F,Bertagnolli S,et al.Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect[J].J Biol Chem,1997,272 (20):13390-13396.
2[2]Muller YA,Christinger HW,Keyt BA,et al.The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93A resolution:multiple copy flexibility and receptor binding[J].Structure,1997,5(10):1325-1338.
3[3]Kraft A,Weindel K,Ochs A,et al.Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease[J].Cancer,1999,85 (1):178-187.
4[4]Poltorak Z,Cohen T,Sivan R,et al.VEGF145,a secreted vascular endothelial growth factor isoform that binds to extracellular matrix[J].J Biol Chem,1997,272(11):7151-7158.
5[5]Marti HH,Risan W.Systemic hypoxia changes the organ specific distribution of vascular endothelial growth factor and its receptors[J].Proc Natl Acad Sci USA,1998,95(26):15809-15814.
6[6]Barleon B,Siemeister G,Marting-Baron G,et al.Vascular endothelial growth factor up-regulates its receptor fms lilk tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells[J].Cancer Res,1997,57 (23):5421-5425.
7[7]Bussolino F,Mantovani A,Persico G.Molecular mechanisms of blood vessel formation[J].TIBS,1997,22 (7):251-256.
8[8]Burleon B,Siemeister G,Marting-Baron G,et al.Vascular endothelia growth factor up regulates it's receptor fms lilk tyrosine kinase (FLT-1)and a soluble variant of FLT-1 in human vascular endothelial cells[J].Cancer Res,1997,57 (23):5421-5425.
9[9]Feng D,Nagy JA,Hipp J,et al.Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor,histamine,and serotonin[J].J Exp Med,1996,183 (5):1981.
10[10]Kim KJ,Li B,Winer J,et al.Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo[J].Nature,1993,362 (6423):841-844.
